Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RUNX2 transcription factor inhibitors and uses thereof

RUNX2 transcription factor inhibitors and uses thereof

US Patent 11634381 · Granted Apr 25, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of extracellular signal-regulated kinase2025
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2025
Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial2024
Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothe2024
Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors2023
Protein translation inhibitors and uses thereof2022
Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelia2022
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2021
Small molecule lipid II inhibitors2021
Small molecule lipid II inhibitors2021
RUNX2 transcription factor inhibitors and uses thereof2019
Method for binding site identification by molecular dynamics simulation (silcs: 2018